Literature DB >> 19773678

Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children.

Jerome A Lindeboom1, Robert Lindeboom, Elisabeth S Bruijnesteijn van Coppenraet, Ed J Kuijper, Jacco Tuk, Jan M Prins.   

Abstract

One hundred children with microbiologically proven nontuberculous mycobacterial cervicofacial lymphadenitis were randomly assigned to excision of the involved lymph nodes, or antibiotic therapy consisting of clarithromycin and rifabutin. The esthetic outcome was rated using a revised and weighted Observer Scar Assessment Scale. The median weighted esthetic outcome in surgical patients was significantly better (30.6) than that for patients treated with antibiotics (42.2).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773678     DOI: 10.1097/INF.0b013e3181aa6411

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections.

Authors:  Jerome A Lindeboom; Lesla E S Bruijnesteijn van Coppenraet; Dick van Soolingen; Jan M Prins; Eduard J Kuijper
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Reliability of the Patient and Observer Scar Assessment Scale When Used With Postsurgical Scar Photographs.

Authors:  Kimberly Shao; James Clayton Parker; Lynne Taylor; Nandita Mitra; Joseph F Sobanko
Journal:  Dermatol Surg       Date:  2018-12       Impact factor: 3.398

Review 3.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

Review 4.  Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.

Authors:  Yu Mi Wi
Journal:  Infect Chemother       Date:  2019-09

5.  Long-term outcome of surgical excision for treatment of cervicofacial granulomatous lymphadenitis in children.

Authors:  Quentin Neven; Dimitri Van der Linden; Marc Hainaut; Sandra Schmitz
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-06       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.